Blog

ASCO20 Virtual Scientific Program: #ASCO20
May 13, 2020 Leslie Fannon Zhang, ASCO staff
Read early research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on quitting smoking and lung cancer survival, recurrent ovarian cancer treatment, geriatric assessment for patients receiving systemic therapy, how Medicaid expansion is impacting U.S. cancer mortality, and using videoconferencing with long-distance caregivers. Read More
May 7, 2020 Norah Lynn Henry, MD
¿Sabía que el cáncer de mama es el cáncer más frecuente en las mujeres de EE. UU., después del cáncer de piel? La Dra. Norah Lynn Henry, editora asociada de Cancer.Net, comparte 9 datos importantes sobre la enfermedad. Read More
May 5, 2020 Brielle Gregory, ASCO staff
In this Clinical Trials in Genitourinary Cancers series podcast, experts discuss 3 clinical trials aiming to identify new treatments for prostate, bladder, and kidney cancers. Read More
May 4, 2020 Richard L. Schilsky, MD, FACP, FSCT, FASCO
La American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) y la National Coalition for Cancer Survivorship (NCCS, Coalición Nacional para la Sobrevivencia del Cáncer) están trabajando juntas para proporcionar información acerca de cómo el coronavirus 2019 (COVID-19) podría afectar la salud y la atención de las personas diagnosticadas con cáncer. Read More
May 3, 2020 Richard L. Schilsky, MD, FACP, FSCT, FASCO
The American Society of Clinical Oncology (ASCO) and the National Coalition for Cancer Survivorship (NCCS) are working together to provide information about how coronavirus 2019 (COVID-19) could potentially affect the health and cancer care of people diagnosed with cancer. Read More

Pages